Stocks and Investing Stocks and Investing
Tue, August 16, 2022
Mon, August 15, 2022

Raghuram Selvaraju Maintained (SPRO) at Strong Buy with Decreased Target to $7 on, Aug 15th, 2022


Published on 2024-10-27 22:39:57 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Spero Therapeutics, Inc." (SPRO) at Strong Buy with Decreased Target from $10 to $7 on, Aug 15th, 2022.

Raghuram has made no other calls on SPRO in the last 4 months.



There are 4 other peers that have a rating on SPRO. Out of the 4 peers that are also analyzing SPRO, 3 agree with Raghuram's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Esther Hong of "Berenberg" Downgraded from Strong Buy to Hold and Held Target at $2 on, Friday, May 20th, 2022
  • Ritu Baral of "Cowen & Co." Downgraded from Buy to Hold on, Wednesday, May 4th, 2022
  • Josh Schimmer of "Evercore ISI Group" Downgraded from Buy to Hold and Decreased Target to $2 on, Wednesday, May 4th, 2022


This is the rating of the analyst that currently disagrees with Raghuram


  • Louise Chen of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $5 on, Tuesday, May 17th, 2022
Contributing Sources